Immediate adverse reactions to intravenous immunoglobulin in primary immune deficiencies: a single center experience.

Nain E., Kıykım A., Kasap N. A., Barış S., Özen A., Aydıner E. K.

The Turkish journal of pediatrics, cilt.62, ss.379-386, 2020 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 62
  • Basım Tarihi: 2020
  • Doi Numarası: 10.24953/turkjped.2020.03.004
  • Dergi Adı: The Turkish journal of pediatrics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.379-386
  • Anahtar Kelimeler: IVIG, adverse reaction, primary immunodeficiencies, COMMON VARIABLE IMMUNODEFICIENCY, REPLACEMENT THERAPY, HUMORAL IMMUNODEFICIENCY, FOLLOW-UP, EFFICACY, CHILDREN, IVIG, CLASSIFICATION, PREVENTION, 5-PERCENT
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background and objective. Adverse reactions related to intravenous immunoglobulin (IVIG) infusions vary from 1 to 81%, with an average of 20%. They may be classified as immediate; occurring during the infusion itself or delayed; occurring after the infusion has been ceased. In the present study, we aimed to evaluate the frequency of immediate adverse reactions due to IVIG infusions in primary immune deficiency (PID) patients.